{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:00:22Z","timestamp":1793754022948,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI153351"],"award-info":[{"award-number":["R01AI153351"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI132606"],"award-info":[{"award-number":["R01AI132606"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lana.2025.101006","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T03:27:29Z","timestamp":1738294049000},"page":"101006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Association between city-level sociodemographic and health factors and the prevalence of antimicrobial-resistant gonorrhea in the US, 2000\u20132019: a spatial\u2013temporal modeling study"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1027-7666","authenticated-orcid":false,"given":"Jingwen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Murray-Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sancta B.","family":"St Cyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5646-1314","authenticated-orcid":false,"given":"Yonatan H.","family":"Grad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-6970","authenticated-orcid":false,"given":"Joshua L.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-5750","authenticated-orcid":false,"given":"Reza","family":"Yaesoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.lana.2025.101006_bib1","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.lana.2025.101006_bib2","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.8.1900118","article-title":"Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018","volume":"24","author":"Jennison","year":"2019","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.lana.2025.101006_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of\u00a0untreatable gonococcal infection","volume":"366","author":"Bolan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12S Suppl 2","key":"10.1016\/j.lana.2025.101006_bib4","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/OLQ.0000000000001548","article-title":"Antimicrobial susceptibility of urogenital and extragenital Neisseria gonorrhoeae isolates among men who have sex with men: strengthening the US response to resistant gonorrhea and enhanced gonococcal isolate surveillance project, 2018 to 2019","volume":"48","author":"Quilter","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"5 Pt 1","key":"10.1016\/j.lana.2025.101006_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-158-5-201303050-00004","article-title":"Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the gonococcal isolate surveillance project, 2005-2010","volume":"158","author":"Kirkcaldy","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lana.2025.101006_bib6","series-title":"Sexually transmitted disease surveillance 2017: gonococcal isolate surveillance project (GISP) supplement and profiles","year":"2019"},{"key":"10.1016\/j.lana.2025.101006_bib7","series-title":"Division of STD prevention, national center for HIV, viral hepatitis, STD, and TB prevention","year":"2022"},{"issue":"4","key":"10.1016\/j.lana.2025.101006_bib8","first-page":"196","article-title":"Assessing the national representativeness of estimates of antimicrobial-resistant urogenital Neisseria gonorrhoeae in US men, gonococcal isolate surveillance project, 2008-2018","volume":"50","author":"Nielsen","year":"2023","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.lana.2025.101006_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility surveillance - the gonococcal isolate surveillance project, 27 sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"issue":"26","key":"10.1016\/j.lana.2025.101006_bib10","first-page":"873","article-title":"Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.lana.2025.101006_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-147-2-200707170-00006","article-title":"Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance","volume":"147","author":"Wang","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.lana.2025.101006_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/sextrans-2021-055298","article-title":"Is there an association between previous infection with Neisseria gonorrhoeae and gonococcal AMR? A cross-sectional analysis of national and sentinel surveillance data in England, 2015-2019","volume":"99","author":"Allen","year":"2023","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.lana.2025.101006_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042893","article-title":"Developing a model to predict individualised treatment for gonorrhoea: a modelling study","volume":"11","author":"Findlater","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.lana.2025.101006_bib14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dkx520","article-title":"Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys","volume":"73","author":"Clifton","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.lana.2025.101006_bib15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1473-3099(13)70143-9","article-title":"Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011","volume":"13","author":"Ison","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.lana.2025.101006_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/sextrans-2016-052583","article-title":"Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales","volume":"93","author":"Town","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"34","key":"10.1016\/j.lana.2025.101006_bib17","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.34.2200081","article-title":"Trends and regional variations of gonococcal antimicrobial resistance in The Netherlands, 2013 to 2019","volume":"27","author":"Visser","year":"2022","journal-title":"Euro Surveill"},{"issue":"36","key":"10.1016\/j.lana.2025.101006_bib18","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.36.1700565","article-title":"Trends and determinants of antimicrobial susceptibility of Neisseria gonorrhoeae in the Netherlands, 2007 to 2015","volume":"23","author":"Hofstraat","year":"2018","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.lana.2025.101006_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/sti.2009.037135","article-title":"Increasing trend in gonococcal resistance to ciprofloxacin in The Netherlands, 2006-8","volume":"86","author":"Koedijk","year":"2010","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.lana.2025.101006_bib20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/jac\/dkab037","article-title":"Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study","volume":"76","author":"Salmeron","year":"2021","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.lana.2025.101006_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12879-021-05931-0","article-title":"Associations between antimicrobial susceptibility\/resistance of Neisseria gonorrhoeae isolates in European Union\/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016","volume":"21","author":"Jacobsson","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.lana.2025.101006_bib22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/OLQ.0000000000000185","article-title":"Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe","volume":"41","author":"Cole","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.lana.2025.101006_bib23","series-title":"Sexually transmitted disease surveillance 2018","author":"Bowen","year":"2019"},{"key":"10.1016\/j.lana.2025.101006_bib24","series-title":"Gonococcal Isolate Surveillance Project (GISP) and enhanced GISP (eGISP)","author":"Cyr","year":"2022"},{"issue":"1","key":"10.1016\/j.lana.2025.101006_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12879-017-2707-z","article-title":"Overall low extended-spectrum cephalosporin resistance but high azithromycin resistance in Neisseria gonorrhoeae in 24 European countries, 2015","volume":"17","author":"Cole","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.lana.2025.101006_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089458","article-title":"Behavioral and socioeconomic risk factors associated with probable resistance to ceftriaxone and resistance to penicillin and tetracycline in Neisseria gonorrhoeae in Shanghai","volume":"9","author":"Trecker","year":"2014","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.lana.2025.101006_bib27","doi-asserted-by":"crossref","first-page":"19330","DOI":"10.2807\/ese.14.37.19330-en","article-title":"Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands","volume":"14","author":"de Vries","year":"2009","journal-title":"Euro Surveill"},{"issue":"15-16","key":"10.1016\/j.lana.2025.101006_bib28","first-page":"243","article-title":"A\u00a0new sexually transmitted infection (STI) in Geneva? Ciprofloxacin-resistant Neisseria gonorrhoeae, 2002-2005","volume":"138","author":"Le Lin","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.lana.2025.101006_bib29","series-title":"Unequal treatment: confronting racial and ethnic disparities in health care","year":"2003"},{"issue":"5","key":"10.1016\/j.lana.2025.101006_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/S40037-020-00602-3","article-title":"Considerations for using race and ethnicity as quantitative variables in medical education research","volume":"9","author":"Ross","year":"2020","journal-title":"Perspect Med Educ"},{"key":"10.1016\/j.lana.2025.101006_bib33","series-title":"Antibiotic prescribing and use","year":"1973"},{"issue":"1","key":"10.1016\/j.lana.2025.101006_bib34","doi-asserted-by":"crossref","DOI":"10.2196\/publichealth.5365","article-title":"Estimating the population sizes of men who have sex with men in US states and counties using data from the American Community Survey","volume":"2","author":"Grey","year":"2016","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.lana.2025.101006_bib35","series-title":"CARBayes version 5.3: an R package for spatial areal unit modelling with conditional autoregressive priors","author":"Lee","year":"2022"},{"key":"10.1016\/j.lana.2025.101006_bib36","series-title":"Statistical models in epidemiology, the environment, and clinical trials","first-page":"179","article-title":"Estimation of disease rates in small areas: a new mixed model for spatial dependence","author":"Leroux","year":"2000"},{"key":"10.1016\/j.lana.2025.101006_bib38","series-title":"Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments","author":"Geweke","year":"1991"},{"key":"10.1016\/j.lana.2025.101006_bib39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.12688\/f1000research.13600.1","article-title":"Epidemiological, behavioural, and clinical factors associated with antimicrobial-resistant gonorrhoea: a review","volume":"7","author":"Abraha","year":"2018","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.lana.2025.101006_bib40","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12879-022-07674-y","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics\u00a0in Urban Hospitals, Lusaka, Zambia","volume":"22","author":"Sarenje","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.lana.2025.101006_bib41","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12879-022-07431-1","article-title":"High burden of untreated syphilis, drug resistant Neisseria gonorrhoeae, and other sexually transmitted infections in men with urethral discharge syndrome in Kampala, Uganda","volume":"22","author":"Hamill","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.lana.2025.101006_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00389-21","article-title":"Demographic and behavioral risk factors associated with reduced susceptibility of Neisseria gonorrhoeae to first-line antimicrobials in South African men with gonococcal urethral discharge","volume":"65","author":"Kularatne","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.lana.2025.101006_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/314625","article-title":"Correlates of gonococcal infection and of antimicrobial-resistant Neisseria gonorrhoeae among female sex workers, Republic of the Philippines, 1996-1997","volume":"179","author":"Klausner","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.lana.2025.101006_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77015","article-title":"Ecology, more than antibiotics consumption, is the major predictor for the global distribution of aminoglycoside-modifying enzymes","volume":"12","author":"Pradier","year":"2023","journal-title":"Elife"},{"issue":"49","key":"10.1016\/j.lana.2025.101006_bib45","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.15585\/mmwr.mm6949a5","article-title":"Notes from the field: first case in the United States of Neisseria gonorrhoeae harboring emerging mosaic penA60 allele, conferring reduced susceptibility to cefixime and ceftriaxone","volume":"69","author":"Picker","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"46","key":"10.1016\/j.lana.2025.101006_bib46","first-page":"1041","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.lana.2025.101006_bib47","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3201\/eid0912.030210","article-title":"International travel and sexually transmitted disease","volume":"9","author":"Etkind","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"50","key":"10.1016\/j.lana.2025.101006_bib48","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC's treatment guidelines for gonococcal infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"}],"updated-by":[{"DOI":"10.1016\/j.lana.2025.101079","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X2500016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X2500016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:24:00Z","timestamp":1746509040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X2500016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":45,"alternative-id":["S2667193X2500016X"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2025.101006","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.lana.2025.101079","asserted-by":"object"}]},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between city-level sociodemographic and health factors and the prevalence of antimicrobial-resistant gonorrhea in the US, 2000\u20132019: a spatial\u2013temporal modeling study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2025.101006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101006"}}